[PDF][PDF] Development of Novel Melatoninergics as Circadian Rhythm Sleep Disorder Therapeutics

KH Chan, AST Cheung, MKC Ho… - … in Melatonin Research, 2013 - researchgate.net
effects, these compounds also show potential anxiolytic and … The other MT2-selective
agonist, UCM765, also induced a … was found to be as effective as diazepam. The high dose of …

Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction

DM Thomson, EJ Mitchell… - Journal of …, 2021 - journals.sagepub.com
… /anxiolytic combining antagonism of 5HT2C receptors with … In mice, an MT2 receptor agonist
(UCM765) decreased anxiety in … sex differences in the effects of melatonin signalling in the …

Possible benefits of considering glutamate with melatonin or orexin or oxytocin as a combination approach in the treatment of anxiety

RR Dhangar, PP Kale, PK Kadu… - Current Pharmacology …, 2020 - Springer
effect in which agomelatine facilitated maturation [37]. Novel MT2 selective partial agonist
UCM765 showed anxiolyticComparison of the effects of melatonin and oxazepam on anxiety …

[HTML][HTML] REM sleep deprivation promotes a dopaminergic influence in the striatal MT2 anxiolytic-like effects

ACD Noseda, ADS Targa, LS Rodrigues, MF Aurich… - Sleep Science, 2016 - Elsevier
… a prevalent locomotor increase compared to MT2 blockade in … activation of MT2 receptors,
by the partial agonist UCM-765, … striatal melatonin MT2 receptors elicited anxiolytic-like effects. …

Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic …

YY Liu, D Yin, L Chen, WM Qu, CR Chen… - …, 2014 - Springer
… motor performance; however, diazepam reduced the time mice … Microinfusion of MT 2 receptor
partial agonist UCM765 into … in mice, piromelatine exerted anxiolytic activity irrespective of …

The melatonergic system in anxiety disorders and the role of melatonin in conditional fear

F Huang, Z Yang, CQ Li - Vitamins and Hormones, 2017 - Elsevier
… During the extinction training phase, a significantly lower freezing was observed in the
melatonin group in comparison to the vehicle group (group, F (1, 18) = 749.594, p < 0.001; group …

Melatonergic drugs in development

A Carocci, A Catalano, MS Sinicropi - … : advances and applications, 2014 - Taylor & Francis
… Membrane-bound melatonin receptors (MT 1 and MT 2 ) … The moderately MT 2 -selective
partial agonist UCM765 has … also reported concerning anxiolytic effects of UCM765 in rats. …

[PDF][PDF] Neuropharmacologic modulation of the melatonergic system

U Aykan, M Güvel, G Paykal… - Exploration of …, 2023 - avesis.gazi.edu.tr
… as an agonist on melatonin MT1 and MT2 receptors. The oral … anxiolytic effects, they may
also exhibit antiepileptic activity [139, 146]. UCM765 is another new agent that acts as an MT2

Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action

MJ Millan - Therapeutic Advances in Psychopharmacology, 2022 - journals.sagepub.com
… as a melatonin (MT 1 /MT 2 ) receptor agonist and 5-HT 2C … ) has been reported to mimic the
anxiolytic properties of MT, … -mentioned MT 2 receptor agonist UCM765 activates neurons in …

Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors

H Bdair, TA Singleton, K Ross, D Jolly… - ACS Chemical …, 2022 - ACS Publications
UCM765 (39) is a selective MT 2 partial agonist which has been reported to promote non-rapid
eye movement sleep maintenance (40) and has anxiolytic (… We hypothesize that UCM765